Current Medical Research and Opinion logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 22, Number 9, September 2006

< previous issue | all issues | next issue >

Original Articles

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations
pp. 1623-1631(9)
Authors: Lefebvre, Patrick; Gosselin, Antoine; McKenzie, R. Scott; Mody, Samir H.; Piech, Catherine Tak; Duh, Mei Sheng

A polysomnography study of eszopiclone in elderly patients with insomnia
pp. 1633-1642(10)
Authors: McCall, W. Vaughn; Erman, Milton; Krystal, Andrew D.; Rosenberg, Russell; Scharf, Martin; Zammit, Gary K.; Wessel, Thomas

Review

Original Article

Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care
pp. 1661-1668(8)
Authors: Ruigómez, Ana; García Rodríguez, Luis Alberto; Wallander, Mari-Ann; Johansson, Saga; Dent, John

Letter to the Editor

Comment and reply on: The dose of aspirin for the prevention of cardiovascular and cerebrovascular events
pp. 1669-1670(2)
Authors: Serebruany, Victor; Fisher, Matt; Knappertz, Volker

Original Articles

A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis
pp. 1671-1678(8)
Authors: Kasper, Lloyd H.; Everitt, Daniel; Leist, Thomas P.; Ryan, Kathleen A.; Mascelli, Mary Ann; Johnson, Kenneth; Raychaudhuri, Aparna; Vollmer, Tim; The Multiple Sclerosis Investigators,

Development of a COPD severity score
pp. 1679-1687(9)
Authors: Wu, E.Q.; Birnbaum, H.G.; Cifaldi, M.; Kang, Y.; Mallet, D.; Colice, G.

Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%
pp. 1689-1697(9)
Authors: García-Feijoo, J.; Martínez-de-la-Casa, J.M.; Castillo, A.; Méndez, C.; Fernández-Vidal, A.; García-Sánchez, J.

Commentary

Single-dose famciclovir for the treatment of herpes labialis
pp. 1699-1702(4)
Authors: Hull, Christopher; Spruance, Spotswood; Tyring, Stephen; Hamed, Kamal

Original Articles

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study
pp. 1715-1723(9)
Authors: Goldstein, Barry J.; Weissman, Peter N.; Wooddell, Margaret J.; Waterhouse, Brian R.; Cobitz, Alexander R.

Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression
pp. 1737-1743(7)
Authors: Schmier, Jordana K.; Halpern, Michael T.; Covert, David W.; Robin, Alan L.

Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial
pp. 1745-1755(11)
Authors: Recker, Robert; Lips, Paul; Felsenberg, Dieter; Lippuner, Kurt; Benhamou, Laurent; Hawkins, Federico; Delmas, Pierre D.; Rosen, Clifford; Emkey, Ronald; Salzmann, Gretel; He, Weili; Santora, Arthur C.

Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study
pp. 1757-1764(8)
Authors: van den Boogaard, C.H.A.; Breekveldt-Postma, N.S.; Borggreve, S.E.; Goettsch, W.G.; Herings, R.M.C.

Review

Health-related quality of life burden of women with endometriosis: a literature review
pp. 1787-1797(11)
Authors: Gao, Xin; Yeh, Yu-Chen; Outley, Jackie; Simon, James; Botteman, Marc; Spalding, James

Original Articles

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension
pp. 1799-1805(7)
Authors: Suzuki, Emilio Rintaro; Meirelles Franklin, Luciana; da Silva, Luciano José Basilio; Figueiredo, Carlos R.L.; Agostini Netto, Joao; Batista, Wagner Duarte

Commentary

Original Articles

Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects
pp. 1813-1823(11)
Authors: Wemer, Johan; Cheng, Yi-Fang; Nilsson, Dag; Reinholdsson, Ingalill; Fransson, Bo; Lanbeck Vallén, Kerstin; Nyman, Lars; Eriksson, Catarina; Björck, Staffan; Schulman, Sam

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
pp. 1825-1837(13)
Authors: Machado, Márcio; Iskedjian, Michael; Ruiz, Inés; Einarson, Thomas R.

Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children
pp. 1839-1847(9)
Authors: Block, Stan L.; Schmier, Jordana K.; Notario, Gerard F.; Akinlade, Bolanle K.; Busman, Todd A.; MacKinnon, George E.; Halpern, Michael T.; Nilius, Angela M.

Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study
pp. 1849-1858(10)
Authors: Holzgreve, Heinrich; Risler, Teut; Trenkwalder, Peter

Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain
pp. 1859-1865(7)
Authors: Bhamb, Bhushan; Brown, David; Hariharan, Jaishree; Anderson, Jane; Balousek, Stacey; Fleming, Michael F.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page